Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05602649 · ClinicalTrials.gov registry record · Phase 1

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

A Phase 1 study of Cannabis Use, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 1
Development phase
80
Enrollment target
1
Study location

NCT05602649 is a Phase 1 study of Cannabis Use that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05602649, a Phase 1 study of Cannabis Use, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study will examine the pharmacokinetics and pharmacodynamics of delta-9-tetrahydrocannabinol (THC)-infused chocolates, gummies, and drinks. Healthy adults (N=40) will complete 9 drug administration sessions, including an overnight stay prior to each session. Participants will consume THC containing products in a fasted state; following drug administration, the participants will complete cognitive and psychomotor tasks, subjective assessments, have blood collected, and vital signs monitored.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Cannabis

Study Locations (1)

Maryland

  • Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-07-10
Est. Completion 2027-01
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05602649

The ClinicalTrials.gov registry entry for NCT05602649 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 278-participant average among 44 other Cannabis Use trials with a reported enrollment target (71% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05602649 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05602649 about?

NCT05602649 is a clinical study titled "The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles". This study will examine the pharmacokinetics and pharmacodynamics of delta-9-tetrahydrocannabinol (THC)-infused chocolates, gummies, and drinks. Healthy adults (N=40) will complete 9 drug administration sessions, including an overnight stay prior to each session. Participants will consume THC contai...

What is the current status of trial NCT05602649?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2024-07-10. Estimated completion is 2027-01.

What conditions does trial NCT05602649 study?

This clinical trial studies the following conditions: Cannabis Use.

What interventions are being tested in trial NCT05602649?

The interventions under investigation include: Placebo (DRUG), Cannabis (DRUG).

Who is sponsoring clinical trial NCT05602649?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05602649 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.